Lengo
Description
Lengo Therapeutics is a biotechnology company focused on developing novel, small-molecule precision therapeutics targeting driver mutations in oncology.
Round Leads
Amount Raised
Prior to its acquisition, Lengo Therapeutics had raised approximately $17.7 million.
About
This company is vetted by the following partner.
Contact them directly for more information >
We've made it simple to share your company's profile with other investors, just share this page
Lengo
Lengo
Description
Lengo Therapeutics is a biotechnology company focused on developing novel, small-molecule precision therapeutics targeting driver mutations in oncology.
Round Leads
Amount Raised
Prior to its acquisition, Lengo Therapeutics had raised approximately $17.7 million.
We've made it simple to share your company's profile with other investors
About
Description
Lengo Therapeutics is a biotechnology company focused on developing novel, small-molecule precision therapeutics targeting driver mutations in oncology.
Round Leads
Amount Raised
Prior to its acquisition, Lengo Therapeutics had raised approximately $17.7 million.
Quick Details
We've made it simple to share your company's profile with other investors, just share this page
About
Lengo